Psychedelic Beacon
Directory›Blog›How to Pay for Ketamine Therapy: Spravato Insurance, HSA/FSA, Superbills, and Financing (2026)
ketamine · cost

How to Pay for Ketamine Therapy: Spravato Insurance, HSA/FSA, Superbills, and Financing (2026)

How to pay for ketamine therapy and Spravato in 2026: insurance rules, prior authorization, J&J withMe savings, Medicare, HSA/FSA, superbills and financing.

Psychedelic Beacon Team

Updated Oct 12, 2026 · Originally published Apr 11, 2026 · 14 min read

The Psychedelic Beacon Team researches and writes educational content about ketamine and psychedelic-assisted therapies to help patients make informed decisions.

Last reviewed: October 2026

Insurance often covers Spravato (esketamine) for depression when strict criteria are met. It rarely covers generic IV ketamine for mental health. Most patients end up combining insurance or J&J's savings programs with HSA/FSA funds, superbills, and careful financing. This guide explains each option, what to check, and what to ask your clinic.

For full price ranges, see our ketamine therapy cost guide. It puts a standard six-session IV series at $2,400 to $4,800, based on PsychedelicBeacon's March 2026 pricing database. For a side-by-side comparison of the two treatments, read Spravato vs ketamine.


Does insurance cover Spravato?

Often, yes. But only for depression, only after prior authorization, and usually only after you've tried other antidepressants first. Here's how each requirement works.

What Spravato is FDA-approved for

According to its FDA prescribing information, Spravato (esketamine) nasal spray is FDA-approved for:

  1. Treatment-resistant depression (TRD) in adults, either alone (monotherapy) or with an oral antidepressant.
  2. Depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior, used with an oral antidepressant.

The FDA approved monotherapy for TRD on January 21, 2025, which Johnson & Johnson announced as "the first and only monotherapy for adults" with TRD. Before then, the TRD approval required an oral antidepressant alongside Spravato.

Coverage is tied to a depression diagnosis, not anxiety

Spravato is not FDA-approved for anxiety. Insurers cover it for the approved depression uses. For example, Aetna's Clinical Policy Bulletin 0950 covers Spravato for TRD or MDD with acute suicidal ideation or behavior, and states that Aetna "considers all other indications as experimental, investigational, or unproven." The diagnosis codes it lists as covered are all depression codes (F32, F33) plus suicidal ideation (R45.851).

If anxiety is your main concern, see our guide to ketamine for anxiety. Ketamine for anxiety is off-label and is almost always self-pay.

Prior authorization

Prior authorization (also called precertification) means your insurer has to approve the treatment before you get it, or the claim can be denied. Aetna's policy says precertification of Spravato "is required of all Aetna participating providers and members in applicable plan designs."

In practice, your prescriber sends records to the insurer. Under Aetna's policy, those records must show:

  • a confirmed diagnosis of severe major depressive disorder, documented with standardized rating scales such as the Beck Depression Inventory, the Hamilton Depression Rating Scale or the Montgomery-Asberg Depression Rating Scale (MADRS)
  • that you're 18 or older
  • that a psychiatrist prescribed the drug or was consulted
  • that you'll be supervised and monitored for at least 2 hours after each dose

Approval isn't permanent. Aetna approves continued TRD treatment in 6-month blocks when rating scales show improvement.

Step therapy: trying other antidepressants first

Many insurers, such as Aetna, use step therapy, meaning you have to show that other treatments didn't work before they'll pay for Spravato. Aetna's policy quotes the FDA's definition of TRD from the original approval: patients with MDD who, "despite trying at least two antidepressant treatments given at adequate doses for an adequate duration in the current episode, have not responded to treatment."

For TRD, Aetna adds two requirements:

  • an inadequate response to two antidepressants from at least two different classes, each taken for at least 8 weeks within the past 5 years
  • an inadequate response to either augmentation therapy (8 weeks or more) or evidence-based psychotherapy such as CBT

Tip: Before the prior authorization is sent, ask your prescriber to pull together your full medication history: drug names, doses, start and stop dates, and side effects.

REMS requirements: why you can't take Spravato home

According to its label and the official Spravato REMS site, Spravato is only available through a restricted FDA program called the Spravato REMS (Risk Evaluation and Mitigation Strategy). That means:

  • It must be given in a REMS-certified healthcare setting. You spray the doses yourself while a healthcare provider watches.
  • You must be monitored for at least 2 hours after each dose.
  • It "must never be dispensed directly to a patient for home use," according to the official Spravato REMS site.
  • Someone else needs to drive you home. The patient materials say not to drive until the next day, after a restful sleep.

To find a certified site, start with our ketamine clinic directory and confirm with the clinic that it's REMS-certified.

J&J's Spravato withMe savings programs (terms verified October 12, 2026)

Johnson & Johnson runs two separate programs for commercially insured patients. We checked these terms on October 12, 2026 against J&J's official Spravato withMe commercial insurance page, the Savings Program requirements and the Observation Rebate Program requirements on Spravato.com.

Spravato withMe Savings ProgramSpravato withMe Observation Rebate Program
What it coversMedicine cost onlyCost of the 2-hour observation only
What you pay"$10 per treatment for SPRAVATO medicine costs""$0 after rebate for observation of each treatment"
Caps and limitsAn annual maximum benefit (dollar amount not published), limited to the medicine's list price. Up to 3 devices per day or 23 devices in a 24-day period. Monthly maximums may applyAn annual maximum benefit (dollar amount not published). Monthly maximums may apply
Not covered"Program does not cover the cost of treatment observation""Program does not cover SPRAVATO medicine cost"
Not valid forAnyone using government insuranceAnyone using government insurance, and residents of MA, MN or RI

Who qualifies for both:

  • Adults 18 or older using commercial or private insurance, including Health Insurance Marketplace plans, who are enrolled in the Spravato REMS.
  • Anyone using "any state or federal government-funded healthcare program" is excluded, including Medicare, Medicaid, TRICARE, the Department of Defense and the VA.
  • No income information is required.

Fine print that matters:

  • Enroll before your treatment. J&J says you must be enrolled "before receiving your SPRAVATO medicine in order to qualify for out-of-pocket cost savings."
  • Send in rebate requests within 365 days of the date of service.
  • If your plan has an "accumulator" or "maximizer" or similar copay program, J&J may lower your annual maximum.
  • The terms expire at the end of each calendar year and can change without notice, so check again every January.
  • You can't seek payment from an FSA or HSA for the value you receive from these programs.

Uninsured, or coverage not enough? J&J says you may be able to get your medicine at no cost for up to one year through the Johnson & Johnson Patient Assistance Program, if you meet its income and eligibility rules. See PatientAssistanceInfo.com or call 833-742-0791.

Medicare and Medicaid basics

Medicare. Medicare pays for Spravato treatment under Part B using two HCPCS codes, created in CMS's CY 2020 physician fee schedule rule:

  • G2082: sessions with up to 56 mg of esketamine
  • G2083: sessions with more than 56 mg

Each code bundles the office visit, the drug and the 2-hour observation into one payment. Part B cost-sharing applies, and the 2026 Part B deductible is $283, according to Medicare.gov. The withMe programs don't apply to Medicare patients.

Medicaid. Each state's Medicaid program sets its own Spravato rules. Some examples:

  • New York Medicaid requires prior authorization and a "trial of at least two oral antidepressants" before Spravato for TRD.
  • Utah publishes its own Spravato prior authorization criteria.
  • Louisiana Medicaid, through the Louisiana Department of Health, requires "clinical authorization for esketamine (Spravato®)." It defines TRD as depression that "has not responded adequately to at least TWO different antidepressants of adequate dose and duration," and approves 4 weeks to start and 6 months to continue.

Check your state Medicaid agency's or your managed care plan's preferred drug list.


Why insurance rarely covers generic ketamine

Off-label status

The FDA approved ketamine as an anesthetic in 1970, so using it for depression, anxiety or PTSD is off-label. In its October 10, 2023 compounding risk alert, the FDA stated that "ketamine is not FDA approved for the treatment of any psychiatric disorder." Insurers generally pay for drugs used for FDA-approved purposes, so IV ketamine infusions for mental health are usually not covered.

What KFF Health News and NPR reported in 2024

In January 2024, KFF Health News published "Ketamine Therapy for Mental Health a 'Wild West' for Doctors and Patients" by Dawn Megli, which NPR republished as "The ketamine economy: New mental health clinics are a 'Wild West' with few rules." The report found:

  • "most insurance doesn't cover ketamine for mental health, so patients must pay out-of-pocket"
  • clinics charge $600 to $1,000 per treatment for a dose that costs them about $1
  • citing Grand View Research, there are 500 to 750 ketamine clinics in the US

Some exceptions exist. For example, Wisconsin Medicaid (ForwardHealth) began covering IV ketamine for MDD with prior authorization on January 1, 2025. Exceptions are rare, so confirm with your own plan.


Other ways to pay for ketamine therapy

Superbills and out-of-network reimbursement

A superbill is an itemized receipt from your provider, with diagnosis codes, service codes, dates and amounts, that you use to file an out-of-network claim yourself. GoodRx calls it "a detailed receipt" that "you can submit to your insurance company for potential reimbursement," and notes "reimbursement isn't guaranteed."

Even if the infusion itself isn't covered, the services around it may be. According to Radial, some clinics bill the initial consultation, labs and follow-up visits to insurance, and documented psychotherapy sessions are often covered too.

Superbills generally only work if your plan has out-of-network benefits, which usually means a PPO or POS plan. According to Sheer Health, you'll usually have to meet a separate out-of-network deductible first. Call your insurer before you start treatment.

HSA and FSA funds

You can use HSA and FSA funds for qualified medical expenses, and IRS Publication 502 defines what counts as medical care:

  • Medical care expenses "must be primarily to alleviate or prevent a physical or mental disability or illness."
  • "You can include in medical expenses amounts you pay for psychiatric care."

The IRS hasn't published guidance that names ketamine specifically. Ask your prescriber for a letter of medical necessity that lists your diagnosis, and keep itemized receipts in case your plan administrator asks for them.

Publication 502 also lets you deduct medical expenses on Schedule A, but only the part above 7.5% of your adjusted gross income. You can't pay for an expense with HSA/FSA money and also deduct it.

Financing: medical credit cards and payment plans

CareCredit is a Synchrony credit card that says it's accepted at more than 285,000 CareCredit Network locations. Its "no interest if paid in full" offers of 6, 12, 18 or 24 months (on purchases of $200 or more) are deferred interest: if any of the promotional balance is left at the end of the period, CareCredit charges interest back to the purchase date. The purchase APR for new accounts is 32.99% (as of May 30, 2024).

In its May 2023 report "Medical Credit Cards and Financing Plans," the Consumer Financial Protection Bureau (CFPB) found:

  • people paid $1 billion in deferred interest on healthcare charges from 2018 to 2020
  • people were charged interest on 20% of healthcare purchases made with deferred-interest cards

Only use a deferred-interest card if you're sure you can pay it off before the promotion ends.

Clinic payment plans. Ask the clinic directly about in-house plans, package pricing or sliding-scale fees. The CFPB warns that providers may not always mention zero-interest repayment options or financial assistance, so ask before you sign up for a credit card.

Psilocybin programs

Licensed psilocybin services in Oregon and Colorado are a separate option from ketamine. Insurance doesn't cover them, because psilocybin has no FDA approval.


What to ask the clinic

Use this checklist before you book.

For Spravato:

  1. Are you certified in the Spravato REMS?
  2. Will you handle the prior authorization, and what medication history do you need from me?
  3. Do you bill Spravato under my medical benefit or my pharmacy benefit? Who submits the withMe rebates, you or me?
  4. What will I owe for the 2-hour observation, and will you give me a receipt I can use for the Observation Rebate Program?
  5. Do you accept Medicare or my state's Medicaid plan?

For IV, IM or oral ketamine:

  1. What's the total price per session and per induction series, including the consultation, any therapy sessions and follow-ups?
  2. Do you provide superbills with diagnosis and service codes? Which items are most likely to be reimbursed?
  3. Do you bill any part of the treatment, like the psychiatric evaluation, to insurance directly?
  4. Do you accept HSA/FSA cards, and will you write a letter of medical necessity?
  5. Do you offer in-house payment plans, package discounts or sliding-scale pricing? If you offer CareCredit, which promotions are available, and are they deferred interest?
  6. What's your refund policy if I stop treatment early?

FAQ

Does insurance cover Spravato for anxiety? No. Spravato is FDA-approved only for TRD and for MDD with acute suicidal ideation or behavior. Insurers such as Aetna treat other uses as experimental.

Can I take Spravato at home? No. Under the Spravato REMS, it's given only in certified healthcare settings with at least 2 hours of monitoring, and it's never dispensed for home use.

Does the Spravato withMe program cover Medicare patients? No. Both withMe programs exclude Medicare, Medicaid, TRICARE, the Department of Defense and the VA.

How much will I pay with withMe? Eligible commercially insured patients pay $10 per treatment for the medicine and $0 after rebate for the observation, up to annual maximums that J&J doesn't publish. We verified these terms October 12, 2026, and they reset every calendar year.

Do I still need an oral antidepressant with Spravato? For TRD, the FDA has allowed Spravato alone since January 2025, though your insurer's policy may still list its own requirements. For MDD with acute suicidal ideation, Spravato is used with an oral antidepressant.

Is IV ketamine covered by insurance? Usually not, because using it for mental health is off-label. A few plans are exceptions, such as Wisconsin Medicaid since January 2025.

Can I use my HSA or FSA for ketamine? Generally yes, when it treats a diagnosed condition. IRS Publication 502 includes psychiatric care as a medical expense. Keep documentation in case your plan asks for it.


Sources

Further reading

Related articles

Ready to find a provider?

Psychedelic Beacon is a directory, not a marketplace. We verify licensure against public registries where we can and mark self-reported claims where we can’t.